OR7E110P

Across TCGA pan-cancer cohorts, OR7E110P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated OR7E110P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher OR7E110P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR7E110P expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

KIRC, HNSC, and UCS are the cancer types where OR7E110P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.762	0.881	<.001	114	view →
HNSC	DFS	Quartile	All	0.814	0.677	.001	43	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
GBM	OS	Tertile	All	0.296	0.466	.004	21	view →
OV	OS	Tertile	III,IV	0.411	0.331	.024	20	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	18	view →
LUSC	OS	Tertile	III,IV	0.769	0.451	.017	13	view →
STAD	OS	Quartile	IV	0.141	0.554	.030	10	view →
DLBC	OS	Tertile	All	0.605	0.941	.034	9	view →
ESCA	DFS	Median	II,III,IV	0.557	0.412	.032	6	view →
BLCA	OS	Quartile	III,IV	0.497	0.324	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

OR7E110P–KIRC (OS)

Open the KIRC breakdown →